platelet dense granule organization

Definition

Target type: biologicalprocess

A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a platelet dense granule. A platelet dense granule is an electron-dense granule occurring in blood platelets that stores and secretes adenosine nucleotides and serotonin. They contain a highly condensed core consisting of serotonin, histamine, calcium, magnesium, ATP, ADP, pyrophosphate and membrane lysosomal proteins. [GOC:dph, PMID:11487378]

Platelet dense granules (DGs) are small, membrane-bound organelles that store a variety of biologically active molecules, including ADP, ATP, serotonin, calcium, and polyphosphate. These molecules play a crucial role in hemostasis, inflammation, and thrombosis. The formation and organization of DGs are complex processes that involve multiple cellular pathways and signaling cascades.

The biogenesis of DGs begins in megakaryocytes, the bone marrow cells responsible for platelet production. During megakaryocyte maturation, pro-DGs, or nascent DGs, arise from the trans-Golgi network (TGN). These pro-DGs contain a specific set of proteins, including the transmembrane protein LAMP-2, which serves as a marker for DGs.

As megakaryocytes mature, pro-DGs undergo a series of maturation steps, including the uptake of specific cargo molecules, such as ADP and serotonin. These molecules are transported to the pro-DGs via specific transporters, such as the serotonin transporter SERT and the nucleoside transporter CNT1.

The organization of DGs within megakaryocytes is crucial for their proper function. DGs are typically clustered near the platelet plasma membrane, which facilitates their rapid release upon platelet activation. This clustering is achieved through interactions between DG proteins and the cytoskeleton, particularly with the actin cytoskeleton.

During platelet formation, megakaryocytes undergo a process called thrombopoiesis, which involves fragmentation of the megakaryocyte cytoplasm into platelets. During this process, DGs are segregated into the platelet cytoplasm.

Platelet activation triggers the release of DG contents into the surrounding environment. This release is mediated by a complex signaling cascade that involves the activation of G protein-coupled receptors (GPCRs), such as the thrombin receptor PAR1. Activation of these receptors triggers a rise in intracellular calcium levels, which in turn activates the calcium-dependent protein kinase C (PKC). PKC then phosphorylates several proteins involved in DG exocytosis, leading to the fusion of DGs with the platelet plasma membrane and the release of their contents.

The release of DG contents plays a critical role in hemostasis by promoting platelet aggregation, vasoconstriction, and the activation of other coagulation factors. ADP released from DGs activates the P2Y12 receptor on other platelets, inducing aggregation. Serotonin released from DGs also contributes to platelet aggregation and vasoconstriction. Calcium released from DGs activates a variety of signaling pathways that promote platelet activation and coagulation.

The organization and function of DGs are tightly regulated, and defects in DG biogenesis, trafficking, or exocytosis can lead to bleeding disorders. For example, patients with Hermansky-Pudlak syndrome, a rare genetic disorder, have defects in DG biogenesis, which can lead to severe bleeding.

In summary, platelet dense granule organization is a complex process that involves multiple steps, including biogenesis, cargo loading, trafficking, and exocytosis. This process is essential for platelet function in hemostasis, inflammation, and thrombosis.'
"

Proteins (2)

Compounds (15)